CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 3, 2012, Pages 429-436

  Wu, Yiming ^a   Luczak, Elizabeth D ^a   Lee, Eun Jeong ^b   Hidalgo, Carlos ^b   Yang, Jinying ^a   Gao, Zhan ^a   Li, Jingdong ^a   H T Wehrens, Xander ^c   Granzier, Henk ^b   Anderson, Mark E ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CaM kinase II; Force frequency relation; Frequency dependent acceleration of relaxation; Phospholamban

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; PHOSPHOLAMBAN;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FORCE FREQUENCY RELATIONSHIP; FREQUENCY DEPENDENT ACCELERATION OF RELAXATION; GENETIC MODEL; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART RATE; ISOLATED HEART; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; HEART; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOFIBRILS; PHOSPHORYLATION;

MURINAE; MUS;

EID: 84864794549     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.06.019     Document Type: Article

References (46)

1. Janssen P.M. Myocardial contraction-relaxation coupling. Am J Physiol Heart Circ Physiol 2010, 299:H1741-H1749.
2. Endoh M. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. Eur J Pharmacol 2004, 500:73-86.
3. Janssen P.M., Periasamy M. Determinants of frequency-dependent contraction and relaxation of mammalian myocardium. J Mol Cell Cardiol 2007, 43:523-531.
4. Varian K.D., Janssen P.M. Frequency-dependent acceleration of relaxation involves decreased myofilament calcium sensitivity. Am J Physiol Heart Circ Physiol 2007, 292:H2212-H2219.
5. Kushnir A., Shan J., Betzenhauser M.J., Reiken S., Marks A.R. Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proc Natl Acad Sci U S A 2010, 107:10274-10279.
6. 2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res 2010, 107:1150-1161.
7. Anderson M.E. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther 2005, 106:39-55.
8. Couchonnal L.F., Anderson M.E. The role of calmodulin kinase II in myocardial physiology and disease. Physiology (Bethesda) 2008, 23:151-159.
9. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003, 4:566-577.
10. Maier L.S. Role of CaMKII for signaling and regulation in the heart. Front Biosci 2009, 14:486-496.
11. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 2007, 73:631-640.
12. Meyer M., Bluhm W.F., He H., Post S.R., Giordano F.J., Lew W.Y., et al. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. Am J Physiol 1999, 276:H779-H785.
13. Bluhm W.F., Kranias E.G., Dillmann W.H., Meyer M. Phospholamban: a major determinant of the cardiac force-frequency relationship. Am J Physiol Heart Circ Physiol 2000, 278:H249-H255.
14. Hagemann D., Kuschel M., Kuramochi T., Zhu W., Cheng H., Xiao R.P. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem 2000, 275:22532-22536.
15. Mattiazzi A., Mundina-Weilenmann C., Guoxiang C., Vittone L., Kranias E. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 2005, 68:366-375.
16. Antoons G., Mubagwa K., Nevelsteen I., Sipido K.R. Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol 2002, 543:889-898.
17. Bombardini T. Myocardial contractility in the echo lab: molecular, cellular and pathophysiological basis. Cardiovasc Ultrasound 2005, 3:27.
18. 2+ leak promotes atrial fibrillation in mice. J Clin Invest 2009, 119:1940-1951.
19. DeSantiago J., Maier L.S., Bers D.M. Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban. J Mol Cell Cardiol 2002, 34:975-984.
20. Valverde C.A., Mundina-Weilenmann C., Said M., Ferrero P., Vittone L., Salas M., et al. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation. J Physiol 2005, 562:801-813.
21. Boontje N.M., Merkus D., Zaremba R., Versteilen A., de Waard M.C., Mearini G., et al. Enhanced myofilament responsiveness upon beta-adrenergic stimulation in post-infarct remodeled myocardium. J Mol Cell Cardiol 2011, 50:487-499.
22. Cazorla O., Lucas A., Poirier F., Lacampagne A., Lezoualc'h F. The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci U S A 2009, 106:14144-14149.
23. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005, 11:409-417.
24. Kadambi V.J., Ball N., Kranias E.G., Walsh R.A., Hoit B.D. Modulation of force-frequency relation by phospholamban in genetically engineered mice. Am J Physiol 1999, 276:H2245-H2250.
25. Wu Y., Shintani A., Grueter C., Zhang R., Hou Y., Yang J., et al. Suppression of dynamic Ca(2+) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition. J Mol Cell Cardiol 2006, 40:213-223.
26. 2+]i transients in cardiac myocytes at physiological stimulation frequencies. Am J Physiol Heart Circ Physiol 2008, 294:H2352-H2362.
27. Lee E.J., Peng J., Radke M., Gotthardt M., Granzier H.L. Calcium sensitivity and the Frank-Starling mechanism of the heart are increased in titin N2B region-deficient mice. J Mol Cell Cardiol 2010, 49:449-458.
28. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
29. Wu Y., Tobias A.H., Bell K., Barry W., Helmes M., Trombitas K., et al. Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy. J Mol Cell Cardiol 2004, 37:111-119.
30. Cazorla O., Wu Y., Irving T.C., Granzier H. Titin-based modulation of calcium sensitivity of active tension in mouse skinned cardiac myocytes. Circ Res 2001, 88:1028-1035.
31. Fabiato A., Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol Paris 1979, 75:463-505.
32. 2+ desensitization in failing rat myocardium. J Physiol 2007, 582:695-709.
33. Tong C.W., Gaffin R.D., Zawieja D.C., Muthuchamy M. Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. J Physiol 2004, 558:927-941.
34. Endoh M. Frequency-dependent inhibition of the intracellular calcium transients by calmodulin antagonists in the aequorin-injected rabbit papillary muscle. Adv Exp Med Biol 1989, 255:461-470.
35. Gao W.D., Perez N.G., Marban E. Calcium cycling and contractile activation in intact mouse cardiac muscle. J Physiol 1998, 507(Pt 1):175-184.
36. Stuyvers B.D., McCulloch A.D., Guo J., Duff H.J., ter Keurs H.E. Effect of stimulation rate, sarcomere length and Ca(2+) on force generation by mouse cardiac muscle. J Physiol 2002, 544:817-830.
37. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 2004, 94:e61-e70.
38. Zhao W., Uehara Y., Chu G., Song Q., Qian J., Young K., et al. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. J Mol Cell Cardiol 2004, 37:607-612.
39. Brixius K., Wollmer A., Bolck B., Mehlhorn U., Schwinger R.H. Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium. Pflugers Arch 2003, 447:150-157.
40. Janssen P.M. Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere. Am J Physiol Heart Circ Physiol 2010, 299:H1092-H1099.
41. Bhupathy P., Babu G.J., Ito M., Periasamy M. Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes. J Mol Cell Cardiol 2009, 47:723-729.
42. Bassani R.A., Mattiazzi A., Bers D.M. CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes. Am J Physiol 1995, 268:H703-H712.
43. Li L., Chu G., Kranias E.G., Bers D.M. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol 1998, 274:H1335-H1347.
44. Vittone L., Mundina-Weilenmann C., Mattiazzi A. Phospholamban phosphorylation by CaMKII under pathophysiological conditions. Front Biosci 2008, 13:5988-6005.
45. 2+ load. Heart Rhythm 2011, 8:784-787.
46. Mattiazzi A., Mundina-Weilenmann C., Vittone L., Said M., Kranias E.G. The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions. Braz J Med Biol Res 2006, 39:563-572.